942 reports of this reaction
3.3% of all DOLUTEGRAVIR SODIUM reports
#4 most reported adverse reaction
ANHEDONIA is the #4 most commonly reported adverse reaction for DOLUTEGRAVIR SODIUM, manufactured by ViiV Healthcare Company. There are 942 FDA adverse event reports linking DOLUTEGRAVIR SODIUM to ANHEDONIA. This represents approximately 3.3% of all 28,565 adverse event reports for this drug.
Patients taking DOLUTEGRAVIR SODIUM who experience anhedonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANHEDONIA is moderately reported among DOLUTEGRAVIR SODIUM users, representing a notable but not dominant share of adverse events.
In addition to anhedonia, the following adverse reactions have been reported for DOLUTEGRAVIR SODIUM:
The following drugs have also been linked to anhedonia in FDA adverse event reports:
ANHEDONIA has been reported as an adverse event in 942 FDA reports for DOLUTEGRAVIR SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANHEDONIA accounts for approximately 3.3% of all adverse event reports for DOLUTEGRAVIR SODIUM, making it a notable side effect.
If you experience anhedonia while taking DOLUTEGRAVIR SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.